Screen for HIV in new GP registrants
Screening for HIV in all newly registered patients in general practice could be cost effective in as little as 13 years, according to a health economic modelling study published in The Lancet HIV.
Routine testing in areas of high HIV prevalence would fall with NICE cost per QALY funding parameters.
The modelling was based on research from the London Borough of Hackney, showing that testing for HIV in patients registering in general practice identified more HIV infected patients and identified earlier disease than control practices.
The model looked at costs of treatment and the costs of onward transmission. The benefits of earlier identification and treatment were also factored in.
According to the authors of the study, general practice-based HIV screening is an important public health intervention that deserves to be scaled up.